YPSOMED HOLDING AG NAM.-AKTIEN S
YPSOMED HOLDING AG NAM.-AKTIEN S/ CH0019396990 /
A0B8VP
05/09/2024 23:00:29
|
Chg.
-0.50
|
Volume |
Bid23:00:29 |
Ask23:00:29 |
Market Capitalization |
Dividend Y. |
P/E Ratio |
446.00EUR
|
-0.11%
|
- Turnover: - |
446.00Bid Size: - |
453.00Ask Size: - |
6.14 bill.EUR |
- |
- |
Fundamentals
|
FY 2024 |
Growth (1Y) |
Per Share |
|
Earnings per Share: |
5.74 CHF |
50.26% |
EPS Diluted: |
- CHF |
50.26% |
Revenues per Share: |
40.18 CHF |
10.25% |
Book Value per Share: |
45.26 CHF |
9.85% |
Cash Flow per Share: |
11.96 CHF |
26.01% |
Dividend per Share: |
2.00 CHF |
53.85% |
Total |
in mill. |
|
Revenues: |
548.46 CHF |
10.25% |
Net Income: |
78.37 CHF |
52.83% |
Operating Cash Flow: |
163.22 CHF |
- |
Cash and Cash Equivalents: |
74.02 CHF |
- |
Valuation Ratios
|
Current |
Latest FY* |
P/E Ratio: |
73.43 |
62.80 |
P/S Ratio: |
10.49 |
8.97 |
P/BV ratio: |
9.31 |
7.97 |
P/CF Ratio: |
35.25 |
30.15 |
PEG: |
1.46 |
1.25 |
Earnings Yield: |
1.36% |
1.59% |
Dividend Yield: |
0.47% |
0.55% |
Market Capitalization |
|
Market Capitalization: |
6.14 bill. EUR |
5.25 bill. EUR |
Free Float Market Cap.: |
- EUR |
- EUR |
Market Cap. / Employee: |
2.57 mill. EUR |
2.2 mill. EUR |
Shares Outstanding: |
13.65 mill. |
|
Profitability
Gross Profit Margin: |
34.47% |
EBIT Margin: |
15.72% |
Net Profit Margin: |
14.29% |
Return on Equity: |
12.69% |
Return on Assets: |
7.12% |
Financial Strength
Liquidity I / Cash Ratio: |
16.81% |
Liquidity II / Quick Ratio: |
45.90% |
Liquidity III / Current Ratio: |
76.77% |
Debt / Equity Ratio: |
78.30% |
Dynam. Debt / Equity Ratio: |
296.32% |
Efficiency
Employees: |
2,389 |
Personal Expenses / Employee: |
- CHF |
Revenues / Employee: |
229,575.97 CHF |
Net Income / Employee: |
32,802.85 CHF |
Total Assets / Employee: |
461,027.63 CHF |
* Fiscal Year End: |
31/03/2024 |
Accounting Standard: |
Swiss GAAP FER |